Jpmorgan Chase & CO Beyond Spring Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.13 - $2.66 $11,870 - $27,943	-10,505 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$1.68 - $5.01 $3,785 - $11,287	2,253 Added 27.3%	10,505 $23,000
Q4 2021 Feb 10, 2022	SELL	$4.02 - $16.84 $39,838 - $166,884	-9,910 Reduced 54.56%	8,252 $37,000
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $168,180 - $568,652	18,162 New	18,162 $286,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.